Salute e Benessere

Evaxion Reinforces Milestone Timeline and Provides Shareholder Update

/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today issued the following letter to shareholders. Dear Fellow Shareholders of Evaxion,The first half of 2024 has been off to a very productive start to the year for Evaxion. We have launched our refined strategy, and we are well positioned for value realization via our three-pronged business model focusing on vaccine target discovery collaborations...
Nasdaq GlobeNewswire
03/07/2024

Neuromod Devices Ltd. Appoints Tom Maher as General Counsel

"I am pleased to announce the appointment of Tom as Neuromod Devices' General Counsel. Tom's extensive background in international business and corporate operations in the life sciences industry will be an invaluable asset to Neuromod Devices as we continue to redefine tinnitus care on a global scale." said Dr. Ross O'Neil, Neuromod Devices Founding CEO. "I am pleased to announce the appointment of Tom as Neuromod Devices' General Counsel. Tom's extensive background in…
PR Newswire
03/07/2024

Consumer goods industry statistics & trends: A US$ 2 trillion opportunity -…

Horizon Databook is the largest market research database with over 1 million data points across 20,000+ markets. The platform is first-in-class and is designed to service a full suite of market research clients. It is a one, five solution platform and includes the following: Horizon Databook is the largest market research database with over 1 million data points across 20,000+ markets. The platform is first-in-class and is designed to service a full suite of market research clients...
PR Newswire
03/07/2024

Animal health market: A high revenue generating industry with revenue crossing…

Horizon has a wide array of animal health topics within its database. Here are the top 10 trending animal health markets: Horizon has a wide array of animal health topics within its database. Here are the top 10 trending animal health markets: About Horizon Databook – The most extensive market research database Horizon Databook is the largest market research database with over 1 million data points across 20,000+ markets. The platform is first-in-class and is designed to service a...
PR Newswire
03/07/2024

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European…

REGULATED INFORMATION INSIDE INFORMATIONNyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment BankMont-Saint-Guibert, Belgium – July 3, 2024, 12:30pm CET / 6:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (“OSA”), today announced that it has signed a €37.5 million loan facility...
Nasdaq GlobeNewswire
03/07/2024

Gupshup and Meta along with Sudan Medical Specialization Board and Shabaka…

This initiative aims to address the urgent healthcare needs of over 800,000 Sudanese refugees who currently have limited access to essential medical services in Egypt and its neighboring countries. By leveraging the chatbot, patients can now connect with healthcare professionals via WhatsApp, making medical assistance more accessible and efficient. This initiative aims to address the urgent healthcare needs of over 800,000 Sudanese refugees who currently have limited access to essential…
PR Newswire
03/07/2024

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q2 2024

Revenue in Zinzino's sales markets increased by 24% in the second quarter of 2024 compared with the same period last year and amounted to SEK 481.9 (387.3) million. Total revenues in the Group increased by 24% in the second quarter and amounted to SEK 505.4 (407.9) million. Revenue in Zinzino's sales markets increased by 24% in the second quarter of 2024 compared with the same period last year and amounted toSEK 481.9(387.3) million. Total revenues in the Group increased by 24% in the...
PR Newswire
03/07/2024

Specialty Enzymes Market worth $9.2 billion by 2029 - Exclusive Report by…

Browse in-depth TOC on "Specialty Enzymes Market" Browse in-depth TOC on "Specialty Enzymes Market" 297 – Tables 70 – Figures 306 – Pages Advancements in enzyme engineering have enabled the discovery of newenzymes from natural sources, ensuring their safety and efficacy in various applications. This includes their use in producing specialty pharmaceuticals and in biocatalytic processes. A recent study by theUniversity of Notre Dameresearchers inJanuary 2022emphasized...
PR Newswire
03/07/2024

Cytotoxic Drugs and HPAPI Manufacturing Market worth USD 27.1 Billion to 2031 -…

Cytotoxic drugs and high-potency active pharmaceutical ingredients (HPAPIs) are indispensable in modern medicine, particularly in oncology where targeted therapies are revolutionizing treatment approaches. Cytotoxic drugs specifically target and destroy cancer cells while minimizing harm to healthy tissues, offering significant therapeutic benefits. HPAPIs, known for their extremely low occupational exposure limits and potent effects at minimal doses, require specialized manufacturing processes…
PR Newswire
03/07/2024

Direct Primary Care Market Size to Reach USD 80.4 Billion by 2031- Latest Report…

The Direct Primary Care (DPC) market refers to the sector of the healthcare industry focused on the delivery and consumption of primary care services through a direct payment model between patients and healthcare providers. In DPC, patients typically pay a periodic fee (monthly or annually) to their primary care physician or practice, which covers a wide range of basic medical services. These services often include preventive care, routine check-ups, chronic disease management, urgent care…
PR Newswire
03/07/2024

Olon Group Announces the Acquisition of GTP Bioways Group

GTP Bioways Group is a French company operating as Biotech CDMO (Contract Developing and Manufacturing Organisation), specialising in R&D Services, process development and production of mAbs, enzymes, proteins, nanodrugs, ADCs and F&F. GTP Bioways Group, with multiple locations across France, specializes in delivering comprehensive services to biopharmaceutical companies. From preclinical development to commercial stages, the group focuses on utilizing cutting-edge technologies to...
Nasdaq GlobeNewswire
03/07/2024

Two Belgian hospitals live with Sectra's public cloud service for medical…

One of the main reasons for this shift was the need to streamline operations and enhance collaboration between the two sites. Since 2021, the 23 radiologists and nine trainees of both hospitals have worked together in one single association. Previously, they were unable to work in one environment as they were using two different PACS providers. This made it much harder to collaborate. This need originates from the challenge many hospitals face today of dealing with heavy workloads. One of the...
PR Newswire
03/07/2024

Barrington James Announces Strategic Acquisition of S3 Science Recruitment

Dan Barrington, CEO of Barrington James, stated: "We are thrilled to acquire S3 and expand our Human Capital services in Life Sciences. This acquisition enhances our offerings across Board and Executive partnerships, Permanent Recruitment, Contract Recruitment, Staffing, OSP, and FSP. S3's expertise in Clinical and Pre-Clinical specializations, both on a temporary and permanent basis, will perfectly complement Barrington James' comprehensive Life Science services, from Clinical to…
PR Newswire
03/07/2024

Philips appoints Ling Liu as Chief Region Leader of Philips Greater China

Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of Philips' Executive Committee, reporting to Philips CEO Roy Jakobs. She succeeds Andy Ho, who has decided to retire after a long and successful career. Ms Liu and Mr Ho continue to work together to ensure a smooth handover.“Ling is a...
Nasdaq GlobeNewswire
03/07/2024

Hansa Biopharma to host Q2 2024 interim results conference call

To participate in the telephone conference, please use the dial-in details provided below: To participate in the telephone conference, please use the dial-in details provided below: Sweden : +46-8-1241-0952 United Kingdom : +44-203-7696819 United States : +1 646-787-0157 Participant access code: 765135 The webcast will be available onhttps://hansabiopharma.eventcdn.net/events/half-year-january-june-2024 Contacts for more information:Evan Ballantyne, Chief Financial...
PR Newswire
03/07/2024

Press Release: Dupixent approved in the EU as the first-ever targeted therapy…

Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two landmark phase 3 studies showing Dupixent significantly reduced exacerbations, improved lung function and also improved health-related quality of lifeDupixent is the first new treatment approach for COPD in more than a decade and a new option for approximately 220,000 adults in the EU ...
Nasdaq GlobeNewswire
03/07/2024

Transplant Oncology Offers New Hope for Intra Hepatic Cholangiocarcinoma

In 2023, a Polish paediatrician (31yrs female) diagnosed with advanced-stage Bile duct cancer faced significant challenges in treatment and prognosis. The CT and MRI revealed a large lesion of 8 x 7 cm size in the right lobe of her liver and several smaller ones (3 x 2 cm) each in the left lobe, indicating a complex case with limited traditional treatment options due to the extensive spread. In 2023, a Polish paediatrician (31yrs female) diagnosed with advanced-stage Bile duct cancer faced...
PR Newswire
03/07/2024

PD-(L)1 Inhibitors Market to Remarkable Growth at a CAGR of 5% by 2034 in the…

Key Takeaways from the PD-(L)1 Inhibitors Market Report Key Takeaways from the PD-(L)1 Inhibitors Market Report Discover which therapies are expected to grab the major PD-(L)1 inhibitors market share @ PD-(L)1 Inhibitors Market Report PD-(L)1 Inhibitors Overview PD-(L)1 inhibitors are a class of immunotherapy drugs that have transformed the treatment landscape for various cancers. The "PD" stands for programmed death, and "L1" refers to its ligand, PD-L1. These inhibitors…
PR Newswire
02/07/2024

Innocan Pharma Engages Pain Management Expert in Preparation for Upcoming FDA…

"We are thrilled to have Dr. Schmidt as part of our LPT-CBD submission expert team," said Iris Bincovich, CEO of Innocan. "His extensive expertise in pain-related clinical development and regulatory affairs will strongly contribute to our LPT-CBD submission process with the FDA. His expertise significantly strengthens our team as we work towards FDA approval." "We are thrilled to have Dr. Schmidt as part of our LPT-CBD submission expert team,"said Iris Bincovich…
PR Newswire
02/07/2024

/C O R R E C T I O N -- Menarini Silicon Biosystems/

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., July 2, 2024 /PRNewswire/ --The Reproductive Precision Medicine Unit of Menarini Silicon Biosystems (MSB) presented last week, at the 21st World Congress of the Fetal Medicine Foundation meeting in Lisbon, Portugal, results of a large multicenter study describing their next generation non-invasive prenatal testing technology using fetal cells isolated from maternal blood. The genomic analysis of these fetal cells showed a high concordance with the…
PR Newswire
02/07/2024

IPSEN - Buy-back programme - Art 5 of MAR - Week 26 - 2024

AggregatedpresentationbydayandbymarketPurchases of own shares from June 24th to 28th 2024 Name of the IssuerIdentity code of the IssuerDay of the transactionIdentity code of the financial instrumentTotal daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code) IPSEN549300M6SGDPB4Z94P1124/06/2024FR00102591503 455115,8742XPARIPSEN549300M6SGDPB4Z94P11...
Nasdaq GlobeNewswire
02/07/2024

Virbac finalizes minority shares' acquisition of Globion, an Indian poultry…

On June 21, we finalized the acquisition of Globion's minority shares, bringing our stake to 100%. As planned, this transaction follows the acquisition of a 74% majority stake concluded on November 1, 2023. Founded in 2005, as a joint venture between Suguna Group, one of the leading Indian poultry conglomerates, and Lohmann Animal Health, a German poultry vaccines specialist, Globion has developed robust know-how and expertise in the development, manufacturing and commercialization of live...
Nasdaq GlobeNewswire
02/07/2024

Global Digital PCR and Real-Time PCR Market Dynamics: Forecasted Growth to USD…

Browse in-depth TOC on "Digital PCR and Real-Time PCR Market" Browse in-depth TOC on "Digital PCR and Real-Time PCR Market" 907 - Tables58 - Figures632 - Pages Key Players in the Market: Danaher Corporation Danaher Corporation (US) holds a prominent position in the global digital PCR (dPCR) and real-time PCR (qPCR) markets, owing to its innovative technologies and strategic acquisitions. The company's portfolio includes high-performance instruments like the...
PR Newswire
02/07/2024

Ascorbyl Glucoside Market Projected to Grow at 6.1%, Reaching $244 Million by…

A naturally occurring antioxidant found in plants, ascorbyl glucoside is a common ingredient in moisturizers, serums, and creams, among other cosmetic goods. The market is being driven forward by rising awareness of antioxidants, a growing number of companies manufacturing cosmetics, and the increasing desire for natural and organic skincare products across the world. Growing demand for skincare and cosmetics products with antioxidant properties is being seen worldwide, which is also fostering…
PR Newswire
02/07/2024
Altri  Comunicati